The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: Results from the GMALL study group

Blood

Volumn 113, Issue 17, 2009, Pages 4011-4015

  Burmeister, Thomas ^a   Meyer, Claus ^b   Schwartz, Stefan ^a   Hofmann, Julia ^b   Molkentin, Mara ^a   Kowarz, Eric ^b   Schneider, Björn ^c   Raff, Thorsten ^d   Reinhardt, Richard ^e   Gökbuget, Nicola ^b   Hoelzer, Dieter ^b   Thiel, Eckhard ^a   Marschalek, Rolf ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MIXED LINEAGE LEUKEMIA PROTEIN; MLL 11Q23 PROTEIN; MLL ACTN4 PROTEIN; MLL AF4 PROTEIN; MLL AF9 PROTEIN; MLL ENL PROTEIN; MLL PTD PROTEIN; MLL TET1 PROTEIN; UNCLASSIFIED DRUG; HYBRID PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; MLL PROTEIN, HUMAN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME BREAKAGE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FUSION GENE; GENE; GENE REARRANGEMENT; GENOMICS; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; GENETICS; HUMAN CHROMOSOME; MEDICAL SOCIETY; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEPRILYSIN; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECOMBINANT FUSION PROTEINS; SOCIETIES, MEDICAL;

EID: 65449144773     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2008-10-183483     Document Type: Article

References (23)

1. Meyer C, Schneider B, Jakob S, et al. The MLL recombinome of acute leukemias. Leukemia. 2006;20:777-784.
2. Szczepański T. Why and how to quantify minimal residual disease in acute lymphoblastic leukemia? Leukemia. 2007;21:622-626.
3. Burmeister T, Marschalek R, Schneider B, et al. Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations. Leukemia. 2006;20:451-457. (Pubitemid 43291743)
4. Ludwig WD, Rieder H, Bartram CR, et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood. 1998;92:1898-1909. (Pubitemid 28446678)
5. Cimino G, Elia L, Mancini M, et al. Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. Blood. 2003;102:2014-2020. (Pubitemid 37122374)
6. Pui CH, Campana D. Age-related differences in leukemia biology and prognosis: the paradigm of MLL-AF4-positive acute lymphoblastic leukemia. Leukemia. 2007;21:593-594. (Pubitemid 46444539)
7. Nilson I, Lochner K, Siegler G, et al. Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. Br J Haematol. 1996;93:966-972. (Pubitemid 26199341)
8. Burmeister T, Schwartz S, Taubald A, et al. Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia. Haematologica. 2007;92:1699-1702. (Pubitemid 350248252)
9. Schwartz S, Rieder H, Schläger B, Burmeister T, Fischer L, Thiel E. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/ CD65s(+)/CD15(+) B-cell phenotype. Leukemia. 2003;17:1589-1595. (Pubitemid 36986961)
10. van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:1901-1928.
11. Jansen MW, Corral L, van der Velden VH, et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia. 2007;21:633-641. (Pubitemid 46444545)
12. Gleissner B, Gökbuget N, Rieder H, et al. CD10-pre-B acute lymphoblastic leukemia (ALL) is a distinct high-risk subgroup of adult ALL associated with a high frequency of MLL aberrations: results of the German Multicenter Trials for Adult ALL (GMALL). Blood. 2005;106:4054-4056. (Pubitemid 41775909)
13. Meyer C, Schneider B, Reichel M, et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc Natl Acad Sci U S A. 2005;102:449-454. (Pubitemid 40116787)
14. Meyer C, Burmeister T, Strehl S, et al. Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia. Leukemia. 2007;21:588-590. (Pubitemid 46306583)
15. Reichel M, Gillert E, Breitenlohner I, et al. Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical research. Cancer Res. 1999;59:3357-3362. (Pubitemid 29334491)
16. Rubnitz JE, Camitta BM, Mahmoud H, et al. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. J Clin Oncol. 1999;17:191-196. (Pubitemid 29022393)
17. Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res. 2002;62:4075-4080. (Pubitemid 34791077)
18. Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia. 2003;17:637-641. (Pubitemid 36395661)
19. Shih LY, Liang DC, Fu JF, et al. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia. 2006;20:218-223.
20. Kaplan JM, Kim SH, North KN, et al. Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet. 2000;24:251-256.
21. Echchakir H, Mami-Chouaib F, Vergnon I, et al. A point mutation in the α-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma. Cancer Res. 2001;61:4078-4083. (Pubitemid 32720974)
22. Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood. 2003;102:2395-2402.
23. Drexler HG, Quentmeier H, MacLeod RA. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Leukemia. 2004;18:227-232. (Pubitemid 38247741)